Beijing Strong BiotechnologiesInc Management
Management criteria checks 3/4
Beijing Strong BiotechnologiesInc's CEO is Xi Liu, appointed in Mar 2011, has a tenure of 13.75 years. directly owns 11.48% of the company’s shares, worth CN¥949.58M. The average tenure of the management team and the board of directors is 13.8 years and 6 years respectively.
Key information
Xi Liu
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 13.8yrs |
| CEO ownership | 11.5% |
| Management average tenure | 13.8yrs |
| Board average tenure | 6yrs |
Recent management updates
Recent updates
Cautious Investors Not Rewarding Beijing Strong Biotechnologies,Inc.'s (SZSE:300406) Performance Completely
Dec 02
Is Beijing Strong BiotechnologiesInc (SZSE:300406) A Risky Investment?
Jul 25Benign Growth For Beijing Strong Biotechnologies,Inc. (SZSE:300406) Underpins Its Share Price
Jul 03An Intrinsic Calculation For Beijing Strong Biotechnologies,Inc. (SZSE:300406) Suggests It's 40% Undervalued
Jun 14Is Now The Time To Put Beijing Strong BiotechnologiesInc (SZSE:300406) On Your Watchlist?
Mar 21Improved Earnings Required Before Beijing Strong Biotechnologies,Inc. (SZSE:300406) Stock's 25% Jump Looks Justified
Mar 03Estimating The Fair Value Of Beijing Strong Biotechnologies,Inc. (SZSE:300406)
Feb 27CEO
Xi Liu (62 yo)
13.8yrs
Tenure
CN¥2,434,400
Compensation
Mr. Xi Liu has been General Manager and Non-Independent Director of Beijing Strong Biotechnologies, Inc. since March 2011. Mr. Liu holds Ph.D.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Non-Independent Director | 13.8yrs | CN¥2.43m | 11.48% CN¥ 949.6m | |
| CFO & Accounting Supervisor | 13.8yrs | CN¥574.90k | 0.027% CN¥ 2.2m | |
| Deputy GM & Non-Independent Director | no data | CN¥1.81m | 0.061% CN¥ 5.0m | |
| Secretary of the Board of Directors | 9.5yrs | CN¥472.80k | 0.071% CN¥ 5.9m | |
| Deputy General Manager | no data | no data | 0.048% CN¥ 4.0m | |
| Deputy General Manager | no data | no data | 0.054% CN¥ 4.4m |
13.8yrs
Average Tenure
47.5yo
Average Age
Experienced Management: 300406's management team is seasoned and experienced (13.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Non-Independent Director | 13.8yrs | CN¥2.43m | 11.48% CN¥ 949.6m | |
| Deputy GM & Non-Independent Director | 4.3yrs | CN¥1.81m | 0.061% CN¥ 5.0m | |
| Chairman of the Board | 13.8yrs | CN¥2.43m | 6.73% CN¥ 556.6m | |
| Non-Independent Director | 13.8yrs | no data | 8.63% CN¥ 714.0m | |
| Non-Independent Director | 13.8yrs | no data | 9.76% CN¥ 807.4m | |
| Chairman of the Supervisory Committee | 7.7yrs | CN¥84.00k | no data | |
| Independent Director | no data | CN¥84.00k | no data | |
| Independent Director | no data | CN¥84.00k | no data | |
| Independent Director | 4.3yrs | CN¥84.00k | no data | |
| Non-Independent Director | 4.3yrs | no data | no data | |
| Non-Independent Director | 1.3yrs | no data | 0.080% CN¥ 6.6m | |
| Independent Director | 1.3yrs | no data | no data |
6.0yrs
Average Tenure
62yo
Average Age
Experienced Board: 300406's board of directors are considered experienced (6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 05:38 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Beijing Strong Biotechnologies,Inc. is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuchang Liu | Changjiang Securities Co. LTD. |
| Mingrui Wang | Everbright Securities Co. Ltd. |
| Wenxin Yu | Haitong International Research Limited |